Skip to content

Clinical trials

Gastrointestinal Stromal Tumors trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Phase: Not applicable Clear all

32 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20071
20081
20092
20113
20121
20141
20164
20171
20181
20192
20202
20212
20222
20231
20242
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status11
Completed9
Recruiting5
Terminated5
Active, not recruiting1
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
First Affiliated Hospital Xi'an Jiaotong University2
RenJi Hospital2
Stanford University2
Affiliated Hospital to Academy of Military Medical Sciences1
Assistance Publique - Hôpitaux de Paris1
Bassem Mohamed Sieda1
Chinese University of Hong Kong1
Dartmouth-Hitchcock Medical Center1
First Affiliated Hospital of Chongqing Medical University1
Gazi University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors32
Stomach Neoplasms7
Carcinoma, Hepatocellular5
Colorectal Neoplasms5
Pancreatic Neoplasms5
Carcinoma, Non-Small-Cell Lung4
Esophageal Neoplasms3
Appendiceal Neoplasms2
Biliary Tract Neoplasms2
Breast Neoplasms2

Trials

Showing 1 to 25 of 32. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.